Home/ Stocks/ MBIO

Mustang Bio, Inc.

MBIO XNAS

$0.81 -0.00 (-0.48%) ▼ 15-min delayed

Open

$0.81

High

$0.83

Low

$0.78

Volume

65.9K

Market Cap

$5.93M

About Mustang Bio, Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 4 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-1,921,000	$-0.39
FY 2025	$0	$-1,921,000	$-0.39
Q3 2025	$0	$-468,000	$-0.07
Q2 2025	$0	$-762,000	$-0.19

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for MBIO yet. Check out our latest market news or earnings calendar.

Get MBIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Mustang Bio, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.